Richard Davis
Professional Bio
Richie has extensive experience with the 340B Program and has worked with both contract pharmacies and covered entities to develop and optimize their program participation. His practice also focuses on a wide variety of pharmacy regulatory issues, including controlled substances and state licensure compliance.
CMS Publishes 340B Drug Acquisition Cost Survey: Respond by May 15, 2020
To Be or Not to 340B Blog ·
HRSA Unveils New 340B Flexibilities During COVID-19 Crisis
To Be or Not to 340B Blog ·
GAO Report Suggests Increased Oversight of 340B Program
To Be or Not to 340B Blog ·
New PBM State Laws Indicate a Shifting Battlefront over 340B Program Drug Pricing
To Be or Not to 340B Blog ·
Interesting 340B Takeaways from 2020 OPPS Proposed Rule
To Be or Not to 340B Blog ·